At a glance
ClinicalIndex Comparison RecordN/ACompleted· 118 enrolled
Drug / intervention
ViBoneother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Post-Market, Multi-Center Study Evaluating ViBone® in Cervical and Lumbar Spine Fusion
In Brief
An observational study evaluating ViBone for Spondylosis and 4 related conditions. Completed, enrolled 118 participants across 4 sites.
Detailed Summary
Assess clinical and radiographic outcomes in patients who undergo 1-3 level anterior cervical discectomy fusion (ACDF) or lumbar interbody fusion (TLIF, PLIF, ALIF, or LLIF) using ViBone.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSpondylosis, Cervical Spondylosis, Spondylolisthesis, Herniated Nucleus Pulposus, Degenerative Disc Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 2018
Enrollment StartMay 2018
Primary CompletionJan 2021
Study CompletionJun 2021
TodayJul 2026
First PostedFeb 7, 2018
Enrollment StartMay 14, 2018
Primary CompletionJan 15, 2021
Study CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 8.4 years ago
Interventions
ViBoneother
Viable Bone Allograft